Articles by Antonio J Vallejo-Vaz

Guest Editorial: Reducing Risk in Familial Hypercholesterolaemia and Severe Dyslipidaemia: Novel Drugs Targeting PCSK9

Antonio J Vallejo-Vaz,

Citation: European Cardiology Review 2018;13(1):7–8.

DOI:

https://doi.org/10.15420/ecr.2018.13.1.GE3
Novel Biomarkers in Heart Failure Beyond Natriuretic Peptides — The Case for Soluble ST2

Antonio J Vallejo-Vaz,

Citation: European Cardiology Review 2015;10(1):37–41

DOI:

https://doi.org/10.15420/ecr.2015.10.01.37